Adjuvant therapy of cutaneous malignant melanoma: a critical review.

about

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

Item

http://www.wikidata.org/entity/Q39827909

description

1985 nî lūn-bûn

@nan

1985年の論文

@ja

1985年学术文章

@wuu

1985年学术文章

@zh-cn

1985年学术文章

@zh-hans

1985年学术文章

@zh-my

1985年学术文章

@zh-sg

1985年學術文章

@yue

1985年學術文章

@zh

1985年學術文章

@zh-hant

name

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

@en

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

@nl

type

Item

label

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

@en

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

@nl

prefLabel

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

@en

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

@nl

P1476

Adjuvant therapy of cutaneous malignant melanoma: a critical review.

@en

P2093

Carey RW

http://www.w3.org/2001/XMLSchema#string

Harmon DC

http://www.w3.org/2001/XMLSchema#string

Koh HK

http://www.w3.org/2001/XMLSchema#string

Lew RA

http://www.w3.org/2001/XMLSchema#string

Sober AJ

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts.

Specific active immunotherapy does not prolong survival in surgically treated patients with stage IIB malignant melanoma and may promote early recurrence.

Multimodal primary cancer treatment (adjuvant chemotherapy): current results and future prospects.

Prognostic value of lymph node dissection in malignant melanoma.

Clinical trials and statistical verdicts: probable grounds for appeal.

Tumour regression and survival of patients with disseminated malignant melanoma treated with chemotherapy and specific active immunotherapy.

Late recurrence of cutaneous melanoma.

Sample size nomograms for interpreting negative clinical studies.

An additional basic science for clinical medicine: III. The challenges of comparison and measurement.

Analysis of survival in cancer clinical trials.

P304

244-260

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MPO.2950130503

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1985-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3897817

http://www.w3.org/2001/XMLSchema#string